Nutritional status is associated with inflammation and predicts a poor outcome in patients with chronic heart failure

Journal of Atherosclerosis and Thrombosis

Volumn 23, Issue 6, 2016, Pages 713-727

  Nakagomi, Akihiro ^a   Kohashi, Keiichi ^a   Morisawa, Taichirou ^a   Kosugi, Munenori ^a   Endoh, Ikuko ^a   Kusama, Yoshiki ^a   Atarashi, Hirotsugu ^a   Shimizu, Wataru ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Chronic heart failure; Inflammation; Malnutrition

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SPIRONOLACTONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; TUMOR NECROSIS FACTOR;

AGED; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CAROTID ATHEROSCLEROSIS; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL READMISSION; HUMAN; INFLAMMATION; KIDNEY FUNCTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MONOCYTE; NEW YORK HEART ASSOCIATION CLASS; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; CHRONIC DISEASE; COMPLICATION; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; SURVIVAL RATE;

AGED; BIOMARKERS; CAROTID INTIMA-MEDIA THICKNESS; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MONOCYTES; NUTRITIONAL STATUS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84971639709     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.31526     Document Type: Article

References (40)

1. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC., El-Menyar AA. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol, 2004; 43: 1439-1444
2. Sargento L, Longo S, Lousada N, dos Reis RP. The importance of assessing nutritional status in elderly patients with heart failure. Curr Heart Dail Rep, 2014; 11: 220-226
3. Otaki M. Surgical treatment of patients with cardiac cachexia. An analysis of factors affecting operative mortality. Chest, 1993; 105: 1347-1351
4. Tevik K, Thürmer H, Husby MI, de Soysa AK, Helvik AS. Nutritional risk screening in hospitalized patients with heart failure. Clin Nutr, 2014; 34: 257-264
5. Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, González P, González B, Mancha A, Rodríguez F, Fernández G. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp, 2005; 20: 38-45
6. El-Menyar AA. Cytokines and myocardial dysfunction: State of the art. J Cardiac Fail, 2008; 14: 61-74
7. Mann DL. Inflammatory mediators and the failing heart. Past, present, and the foreseeable future. Circ Res, 2002; 91: 988-998
8. Hirasawa Y, Nakagomi A, Kobayashi Y, Katoh T, Mizuno K. Short-term amiodarone treatment attenuates the production of monocyte cytokines and chemokines by C-reactive protein and improves cardiac function in patients with idiopathic dilated cardiomyopathy and ventricular tachycardia. Circ J, 2009; 73: 639-646
9. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med, 1990; 323: 236-241
10. Hasper D, Hummel M, Kleber FX, Reindl I, Volk HD. Systemic inflammation in patients with heart failure. Eur Heart J, 1998; 19: 761-765
11. Lorenz MZ, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systemic review and meta-analysis. Circulation, 2007; 115: 459-467
12. Adams MR, Nakagomi A, Keech A, Robinson J, McCredie R, Bailey BP, Freedman SB, Celermajer DS. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation, 1995; 92: 2127-2134
13. Cao JJ, Arnold AM, Manolio TA, Polak JF, Psaty BM, Hirsch CH, Kuller LH, Cushman M. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality. The cardiovascular health study. Circulation, 2007; 116: 32-38
14. Suzuki J, Kurosu T, Kon T, Tomaru T. Impact of cardiovascular risk factors on progression of arteriosclerosis in younger patients: evaluation by carotid duplex ultrasonography and cardio-ankle vascular index(CAVI). J Atheroscler Thromb, 2014; 21: 554-562
15. Su TC, Liao CC, Chien KL, Hsu SH, Sung FC. An overweight or obese status in childhood predicts subclinical atherosclerosis and prehypertension/hypertension in young adults. J Atheroscler Thromb, 2014; 21: 1170-1182
16. Nakagomi A, Freedman SB, Gezcy CL. Interferon-γ and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein. Relationship with age, sex, and hormone replacement treatment. Circulation, 2000; 101: 1785-1791
17. Nakagomi A, Seino Y, Endoh Y, kusama Y, Atarashi H, Mizuno K. Upregulation of monocyte proinflammatory production by C-reactive protein is significantly related to ongoing myocardial damage and future cardiac events in patients with chronic heart failure. J Cardiac Fail, 2010; 16: 562-571
18. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, Fujimoto S, Konta T, Yokoyama H, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol, 2009; 13: 621-630
19. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet, 1999; 353: 1838-1842
20. Stoll LL., Denning GM, Weintraub NL. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol, 2004; 24: 2227-2236
21. Rauchhaus M, Coats AJS, Anker SD. The endotoxinlipoprotein hypothesis. Lancet, 2000; 356. 930-933
22. Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S, Schroedl W, Karhausen T, Doehner W, Rauchhaus M, Poole-Wilson P, Volk HD, Lochs H, Anker SD. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol, 2007; 50: 1561-1569
23. Nakagomi A, Seino Y, Noma S, Kohashi K, Kosugi M, Kato K, Kusama Y, Atarashi H, Shimizu W. Relationships between the serum cholesterol levels, production of monocyte proinflammatory cytokines and long-term prognosis in patients with chronic heart failure. Intern Med, 2015; 53: 2415-2424
24. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine, 1992; 4: 361-368
25. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J, 2005; 26: 11-17
26. Scrutinio D, Passantino A, Santoro D, Catanzaro R. The cardiorenal anaemia syndrome in systolic heart failure: prevalence, clinical correlates, and long-term survival. Eur J Heart Fail, 2011; 13: 61-67
27. Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D. Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol, 2006; 38: 295-310
28. Ronco C, Cicoira M, McCullough PA. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol, 2012; 60: 1031-1042
29. Springer J, Filippatos G, Akashi YJ, Anker SD. Prognosis and therapy approaches of cardiac cachexia. Curr Opin Cardiol, 2006; 21: 229-233
30. Anker SD, Coats AJ. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest, 1999; 115: 836-847
31. Ajayi AA, Adigun AQ, Ojofeitimi EO, Yusuph H, Ajayi OE. Anthropometric evaluation of cachexia in chronic congestive heart failure: the role of tricuspid regurgitation. Int J Cardiol, 1999; 71: 79-84
32. Pasini E, Aquilani R, Gheorghiade M, Dioguardi FS. Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach. Ital Heart J, 2003; 4: 232-235
33. Nochioka K, Sakata Y, Takahashi J, Miyata S, Miura M, Takada T, Fukumoto Y, Shiba N, Shimokawa H; CHART-2 Investigators. Prognostic impact of nutritional status in asymptomatic patients with cardiac diseases. A report from the CHART-2 Study. Circ J, 2013; 77: 2318-2326
34. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J, 2012; 33: 1787-1847
35. Engström G, Melander O, Hedblad B. Carotid intimamedia thickness, systemic inflammation, and incidence of heart failure hospitalizations. Arterioscler Thromb Vasc Biol, 2009; 29: 1691-1695
36. Nelson JJ, Liao D, Sharrett AR, Folsom AR, Chambless LE, Shahar E, Szklo M, Eckfeldt J, Heiss G. Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol, 2000; 15: 468-477
37. Ishizaka N, Ishizaka Y, Nagai R, Toda E, Hashimoto H, Yamakado M. Association between serum albumin, carotid atherosclerosis, and metabolic syndrome in Japanese individuals. Atherosclerosis, 2007; 193: 373-379
38. Lapenna D, Ciofani G, Ucchino S, Pierdomenico SD, Cuccurullo C, Giamberardino MA, Cuccurullo F. Serum albumin and biomolecular oxidative damage of human atherosclerotic plaques. Clin Biochem, 2010; 43: 1458-1460
39. von Haehling S, Doehner W, Anker SD. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res, 2007; 73: 298-309
40. Fudim M, Wagman G, Altschul R, Yucel E, Bloom M, Vittorio TJ. Pathophysiology and treatment options for cardiac anorexia. Curr Heart Fail Rep, 2011; 8: 147-153